EU Health Claims for Botanicals: What Supplement Brands Can Say in 2026

Food supplement capsules being checked on a production line

Image: Freepik

You can import the finest ashwagandha, turmeric or bacopa extract into Europe and still get into trouble because of one sentence on the label. Health claims for botanicals are one of the most confusing parts of EU food law: a huge list of claims has been "on hold" for over a decade, national authorities have taken different views, and in April 2025 the EU's highest court narrowed the room for manoeuvre further. Here's a plain-language overview for brands and importers selling botanical food supplements in the EU.

In short: health claims on foods, including supplements, must be authorised under Regulation (EC) No 1924/2006. Almost no botanical claims have been authorised; most sit on an "on hold" list. In 2025 the Court of Justice ruled that health claims about botanicals can't be made without authorisation unless they're allowed under the transitional rules. Many brands now rely on authorised claims for vitamins or minerals in the formula, or on neutral descriptive wording. Medicinal claims are never allowed on foods.

The basic rule

Under the Nutrition and Health Claims Regulation, (EC) No 1924/2006, a health claim is any statement that suggests a relationship between a food or one of its ingredients and health. "Supports joint comfort", "helps you relax" and "for healthy digestion" are all health claims. They may only be used if they appear on the EU list of authorised claims, with the authorised wording and conditions of use, or if a transitional rule allows them.

On top of that, food law forbids claiming that a food prevents, treats or cures a disease. That's medicinal territory, whatever the ingredient.

What "on hold" means

When the EU built its list of authorised "general function" claims, EFSA assessed thousands of proposed claims. Many claims for vitamins, minerals and other substances were approved or rejected. Claims for plants and plant extracts, though, raised a difficult question: should traditional use count as evidence, as it can for traditional herbal medicines? In 2010 the European Commission paused the assessment of botanical claims to think about it. That pause never ended. The botanical claims have stayed on an "on hold" list ever since.

For years, the Commission's position was that on-hold botanical claims could continue to be used under the responsibility of the business, provided they complied with the regulation's general principles and with national rules. In practice, national authorities applied this very differently.

The 2025 Court of Justice ruling

On 30 April 2025, in case C-386/23 (Novel Nutriology), the Court of Justice of the EU ruled that health claims about botanical substances cannot be made without authorisation while they are pending evaluation, unless they are permitted under the regulation's transitional provisions. The court also made clear that this doesn't stop botanical supplements being sold. It restricts what can be said about them.

The transitional route is in Article 28 of the regulation. Broadly, claims submitted for assessment under Article 13 may continue in line with the regulation and national provisions until the EU list is completed, and some claims approved under earlier national rules can continue under stricter conditions. How far these provisions protect a given claim depends on its history and on the member state, which is why legal advice on specific wording is worth paying for.

Wording options brands use

ApproachExampleRisk level
Authorised claim for a vitamin or mineral in the product"Vitamin C contributes to the normal function of the immune system." (product must meet the conditions of use)Low, if conditions are met
Neutral description of the ingredient"With ashwagandha root extract, standardised to 5% withanolides"Low
Traditional-use or origin information without a health effect"Ashwagandha has been used in Ayurveda for centuries"Medium: context can turn it into an implied claim
On-hold botanical claim relied on under transitional rulesA claim worded exactly as submitted, where national rules permitHigher since 2025; needs legal review per market
Disease or medicinal claim"Relieves arthritis", "treats anxiety"Not allowed on foods

A related rule catches many brands: general wording such as "supports wellbeing" must be accompanied by a specific authorised claim (Article 10(3)). So a vague benefit with no authorised claim next to it is itself a problem.

Other routes: traditional herbal medicines

If a health indication is central to your product, some companies take the medicinal route. Under the EU's traditional herbal medicinal products directive (2004/24/EC), a product with long-standing use can be registered as a traditional herbal medicine and carry an indication based on that tradition. It's a heavier process, with pharmaceutical quality standards and national registration, but it's the legal home for health indications on herbal products.

What about the UK and the USA?

Great Britain has its own nutrition and health claims register, which kept the on-hold approach after Brexit; EU court rulings made after Brexit don't automatically apply there, so check GB rules separately. In the USA, dietary supplements can carry structure/function statements under DSHEA, with an FDA notification and the standard disclaimer, but not disease claims. The same extract can therefore carry different words in each market.

Practical tips for brands

  • Keep botanical labels factual: plant name, part, extract type and standardisation.
  • If you want a health claim, build it on an authorised vitamin or mineral claim and meet its conditions of use.
  • Check your website, social posts and influencer content too: they count as claims.
  • Get a regulatory review per member state before launch.
  • Make sure the ingredient itself is permitted in each market; for example, see ashwagandha's status in Europe.
In the EU, the extract can be excellent and the claim still illegal. Budget for label review as seriously as for ingredient testing.

Supplying EU brands from India

Arizone International LLP supplies standardised herbal extracts and capsules to brands across the EU, with specifications and batch COAs that support accurate, descriptive labelling. Claims and label wording are the brand's responsibility, but we're glad to supply the technical data your regulatory team needs. Our EU import guide covers the ingredient side.

This article is general information, not legal advice. Claim rules and national practice vary and change; have your labels and marketing reviewed by a qualified regulatory adviser for each market.

Sources: Regulation (EC) No 1924/2006; European Journal of Risk Regulation: Case C-386/23, Novel Nutriology; Directive 2004/24/EC.

FAQ

Botanical Claims Questions

Very few. Most botanical claims have been "on hold" since 2010 and have never been assessed, so they don't appear on the EU list of authorised claims.

In case C-386/23, the court ruled that health claims about botanical substances can't be made without authorisation while pending evaluation, unless the regulation's transitional provisions allow them.

Yes. The rules restrict what you say about the botanical, not the sale of the product itself, provided the ingredient is permitted in each market.

Many brands use authorised claims for vitamins or minerals included in the formula, meeting their conditions of use, plus neutral descriptions of the botanical. Always get a legal review for each market.

Supplying the EU Market?

Tell us your product and market, and we'll send specifications and batch documents your regulatory team can work with.